Since the Apaf-1 expression is significantly reduced in melanomas and overexpression of Apaf-1 enhances anticancer drug-induced apoptosis, reversion of the reduced Apaf-1 expression should be considered in the design of novel strategies for the treatment of melanoma patients. The gene discussed is APAF1; the disease is melanoma.